Normal Prostacyclin-Like Activity in Thrombotic Thrombocytopenic Purpura

• References

• 1 Kwaan HC. The pathogenesis of thrombotic thrombocytopenic purpura. Sem Thromb Haemostas 1979; 5: 184-198
• 2 Weisenburger DD, Fry GL, Hoak JC. Thrombotic thrombocytopenic purpura: conflicting results of in-vitro studies. Lancet 1980; 1: 99-100
• 3 Hensby CN, Lewis PJ, Hilgord P, Mufti GJ, Hows J, Webster J. Prostacyclin deficiency in thrombotic thrombocytopenic purpura. Lancet 1979; 2: 748
• 4 Machin SJ, Defreyn G, Chamone DA F, Carreras L, Vermylen J. Serial 6-Keto PGE_1α levels in thrombotic thrombocytopenic purpura. Sixth International Congress on Thrombosis of the Mediterranean League against Thromboembolic Diseases. Monte Carlo: 10/1980: 23-25 (Abstract)
• 5 Remuzzi G, Misiani R, Mecca G, DeGaetano G, Donati MB. Thrombotic thrombocytopenic purpura - A deficiency of plasma factors regulating platelet-vessel wall interaction?. N Engl J Med 1978; 299: 311
• 6 Moncada S, Higgs EA, Vane TR. Human arterial and venous tissues generate prostacyclin (Prostaglandin X), a potent inhibitor of platelet aggregation. Lancet 1977; 1: 18-20
• 7 Budd GT, Bukowski RM, Lucas FV, Cato AE, Cocchetto DM. Prostacyclin therapy of thrombotic thrombocytopenic purpura. Lancet 1980; 2: 915